发明名称 |
TREATMENT OF HYPERPROLIFERATIVE DISORDERS |
摘要 |
A method of treating a hyperproliferative disorder in a subject in need of such treatment, comprising administering to said subject, in combination, a treatment effective amount of: (a) a ceramide-generating retinoid such as fenretinide or a pharmaceutically acceptable salt thereof; and (b) at least one (and in certain embodiments at least two) ceramide degredation inhibitor, such as compounds selected from the group consisting of (i) glucosylceramide synthesis inhibitors, (ii) sphingosine-1-phosphate synthesis inhibitors, and (iii) protein kinase C inhibitors. A preferred glucosyl ceramide synthesis inhibitor is 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol. A preferred sphingosine-1-phosphate synthesis inhibitor is D-erytho-N,N-dimethylsphingosine. A preferred protein kinase C inhibitor is L-threo-dihydrosphingosine.
|
申请公布号 |
WO0000207(A9) |
申请公布日期 |
2000.05.18 |
申请号 |
WO1999US14591 |
申请日期 |
1999.06.28 |
申请人 |
CHILDREN'S HOSPITAL OF LOS ANGELES;MAURER, BARRY, JAMES;REYNOLDS, C., PATRICK;CABOT, MYLES |
发明人 |
MAURER, BARRY, JAMES;REYNOLDS, C., PATRICK;CABOT, MYLES |
分类号 |
A61K45/00;A61K31/07;A61K31/133;A61K31/165;A61K31/167;A61K31/535;A61K31/5375;A61K31/6615;A61K31/70;A61K31/7032;A61K45/06;A61P35/00;A61P43/00;(IPC1-7):A61K31/70;A61K31/13;A61K31/66;A61K31/20 |
主分类号 |
A61K45/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|